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Abstract
PLIN4 is a member of the PAT family of lipid storage droplet (LSD) proteins. Associations between seven single nucleotide
polymorphisms (SNPs) at human PLIN4 with obesity related phenotypes were investigated using meta-analysis followed by
a determination if these phenotypes are modulated by interactions between PLIN4 SNPs and dietary PUFA. Samples
consisted of subjects from two populations of European ancestry. We demonstrated association of rs8887 with
anthropometrics. Meta-analysis demonstrated significant interactions between the rs8887 minor allele with PUFA n3
modulating anthropometrics. rs884164 showed interaction with both n3 and n6 PUFA modulating anthropometric and lipid
phenotypes. In silico analysis of the PLIN4 39UTR sequence surrounding the rs8887 minor A allele predicted a seed site for
the human microRNA-522 (miR-522), suggesting a functional mechanism. Our data showed that a PLIN4 39UTR luciferase
reporter carrying the A allele of rs8887 was reduced in response to miR-522 mimics compared to the G allele. These results
suggest variation at the PLIN4 locus, and its interaction with PUFA as a modulator of obesity related phenotypes, acts in part
through creation of a miR-522 regulatory site.
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Introduction
The World Health Organization (WHO) estimates 1.6 billion
people are overweight, and 400 million obese (www.who.int). Those
affected are at increased risk for occurrence of cardiovascular
diseases (CVD) and other chronic conditions that reduce both
quality of life and life expectancy [1,2]. The basis for obesity is the
inability of the individual to maintain the balance between energy
uptake, storage and expenditure. Adipose tissue plays a critical role
in this complex equilibrium, as well as protecting against the
potential lipo-toxic damage of circulating free fatty acids (FFAs) by
acting as an intracellular sink for triacylglycerols (TAG) in lipid
storage droplets (LSDs) [3]. It has been hypothesized that some of
the adverse metabolic consequences related to obesity are the result
ofsaturatingthe bufferingcapacitiesoftheadiposetissueresultingin
an overflow of FFAs toward other non-adipose tissues, a process
which has been associated with insulin resistance and decreased
clearance of TAG rich particles [4].
PLIN4 is a member of the PAT family of LSD proteins, also
known as the Perilipins PLIN1/perilipin (PLIN), PLIN2/adipose
differentiation related protein (ADRP), PLIN3/tail interacting protein 47
(TIP47), PLIN4/S3-12 and PLIN5/Lipid Storage Droplet Protein 5
(LSDP5) [5]. PLIN4 is expressed mainly in adipose and relocates
to forming LSDs from a scattered distribution in the cytoplasm of
3T3-L1 cells when stimulated with insulin and oleate. Upon their
removal, PLIN4 returns to its basal state location in the cell
periphery suggesting PLIN4 facilitates uptake of FFAs from the
blood to the LSD in response to the nutritional state of the cell [6].
Importantly, several in vivo and in vitro studies support the relevant
role of PLIN1, and the other PATs, in the regulation of LSD TAG
stores [6,7,8].
It has been proposed that common complex diseases occur as a
consequence of common genetic variation - the common disease,
common variant hypothesis [9]. In this scenario risk for disease is
dependent on the collective contribution of genetic variants, with
small to moderate effect size, which an individual may carry [9].
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identified numerous SNPs influencing obesity risk but many of
these associations have not been replicated, partly due to weak
experimental design and to potential interactions between multiple
genetic and non-genetic factors, such as diet [10,11,12]. Thus, the
need to investigate these interactions to define more precisely, both
an individual’s disease risk and the most appropriate therapeutic
approach.
The promoter regions of PLIN1 and PLIN4 contain conserved
and functional peroxisome proliferator-activated receptor (PPAR)
response-elements (PPREs) [8]. PPARs are a family of nuclear-
receptor transcription factors that modulate many aspects of lipid
metabolism [13]. Polyunsaturated fatty acids (PUFA) are known
ligands for PPAR receptors suggesting PAT genes respond to
dietary lipids at the transcriptional level. Interestingly, several
human studies showed that genetic variation at the PLIN1 locus
associates with anthropometric phenotypes in female subjects
[14,15,16]. Moreover, other studies have demonstrated gene by
environment interactions for PLIN1 influencing weight in response
to Rosiglitazone and insulin resistance levels for women consum-
ing diets high in saturated fat [17,18].
Although there have been numerous functional investigations
into variants located in the promoter regions of candidate genes
little attention has been given to variants falling in the 39UTR
where microRNAs (miR)s may bind. miRs regulate protein
output, and individual miR-to-target mRNA interactions may
act to dampen mRNA translation often by 33% or less [19]. In line
with the common disease-common variant hypothesis it has been
proposed that variants mapping within miR targets, or which
create novel miR-to-target interactions, have functional conse-
quence resulting in subtle phenotypic variation [20].
We hypothesize that variation in human PLIN4 may modulate
obesity related phenotypes. To explore this, we performed a
sample size weighted meta-analysis using results from association
analysis of seven PLIN4 SNPs with anthropometric, lipid and
glucose variables in two populations, the Genetics of Lipid
Lowering Drugs and Diet Network (GOLDN) and the Framing-
ham Offspring Study (FOS). We also investigated the interaction
of dietary PUFA n3 and n6 with PLIN4 SNPs to determine their
combined potential to modulate these phenotypes. In silico pre-
diction for SNPs falling in PLIN4 regulatory regions was done to
assess their potential for functional consequence. Our results
indicated the rs8887 SNP creates a miR-522 miR recognition
element (MRE) in the PLIN4 39UTR. The ability of miR-522 to
regulate PLIN4 39UTR was examined. We investigated how
genetic drift in the PLIN4 39UTR in combination with environ-
mental exposures may act in concordance, predisposing individ-
uals to obesity. Although our association results were not adjusted
for multiple tests, the combined evidence of meta-analysis and
functional ex-vivo data, indicates rs8887 as a modulator of anthro-
pometrics in humans.
Results
Meta-analysis of PLIN4 variants with anthropometric, lipid
and glucose related phenotypes from the FOS and
GOLDN populations
The demographic and biochemical characteristics of partici-
pants for the FOS and GOLDN populations varied slightly, and
are presented in Table 1. Genotypic characteristics are shown in
Table 2. Genotype distributions did not deviate from Hardy-
Weinberg equilibrium. Linkage disequilibrium (LD) between SNPs
varied slightly between populations (Figure 1).
To test for overall significance of association of PLIN4 SNPs
with phenotypes of interest, we performed a meta-analysis that
revealed significant associations between rs8887 and BMI
(P=0.002), weight (P=0.017) and a nominal association with
waist circumference (P=0.056) with minor allele carriers having
elevated measures in each case (Table 3). We report here only
those associations for SNPs showing consistent trends with
supporting functional hypotheses. A complete list of our findings
can be viewed in Table S1. The direction of these effects is in
agreement with those reported for the FOS and GOLDN
populations. For our main effect analyses, variation at rs8887
explained 0.4% and 0.33% of variance of BMI in FOS and
GOLDN, respectively.
Meta-analysis of interaction of dietary n3 and n6 PUFA
with PLIN4 variants on anthropometric, lipid and glucose
related phenotypes from the FOS and GOLDN
populations
We performed a meta-analysis of interaction between PLIN4
SNPs and PUFA n3 and n6.The interaction between PUFA n3 and
rs8887 showed significant association modulating BMI (P=0.0144),
weight (P=0.0068) and waist circumference (P=0.0145) where
minor allele carriers showed reduced anthropometrics in response
to PUFA n3 compared to non-carriers. An interaction between
rs884164 and PUFA n3 showed BMI (P=0.008), weight
(P=0.005), waist (0.035), glucose (P=0.0167) and TAG
(P=0.0144) levels are increased in carriers of the minor allele with
elevated PUFA n3 intake (Table 4). Furthermore, rs884164
showed significant interaction with PUFA n6 with HDL
(P=0.036)levelsdecreasing and TAG(P=0.012)increasing among
minor allele carriers with elevated PUFA n6 intake (Table 4).
Performing the meta-analysis separately for each gender
revealed several associations in the male population. Interactions
were observed between rs884164 and PUFA n3 in which BMI
(P=0.037), weight (P=0.028), glucose (P=0.017) and TAG
(P=0.001) levels were modulated. The minor allele subjects
showed elevated levels for each trait, compared to non-carriers.
The percent of variance was calculated for anthropometric traits
explained by the interaction of PLIN4 variants and PUFA intake.
Variation at rs8887 and PUFA n3 intake explained 0.48% and
0.77% of variance in BMI in FOS and GOLDN, respectively.
Variation at rs884164 and PUFA n3 intake explained 0.17% and
0.13% of variance in BMI in FOS and GOLDN, respectively
(Table 4).
Association of PLIN4 variants with visceral and
subcutaneous fat measurements from the FOS
population
Visceral adipose tissue (VAT) has been shown to correlate better
with obesity related phenotypes such as insulin resistance and
CVD than the more traditional anthropometrics [21]. We
performed an association analysis with PLIN4 SNPs and
volumetric computed tomography measures from a subset of the
FOS study for whom those measures were taken. rs8887 associated
with VAT (P=0.003) where carriers of the minor allele showing
increased volume compared to non-carriers. In addition carriers of
the rs8887 minor allele showed increased subcutaneous adipose
tissue (SAT) (P=0.011) compared to non-carriers. Performing our
analyses by gender revealed an association with rs8887 and VAT
(P=0.00059) with only male carriers having greater volume than
non-carriers (Table 3). Variation in rs8887 explained 0.75% of
variance in VAT and 0.56% of variance in SAT in the FOS
population.
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We investigated if variants showing the most consistent
associations may be functional. Using CEU data from HapMap
we determined that rs8887 was not in LD with other known SNPs.
As rs8887 is located in the 39UTR of the PLIN4 mRNA, we
searched for miRs predicted to bind the PLIN4 mRNA using
Targetscan.org and microRNA.org [22,23]. Both programs
predicted the binding of miR-522 with perfect complementarity
to a seed site in the PLIN4 mRNA when containing the minor A
allele (Figure 2). In HapMap, rs884164 was estimated to be in
Table 1. Demographic and biochemical characteristics of FOS & GOLDN subjects.
Men Women
FOS (N=1259) GOLDN (N=481) FOS (N=1352) G0LDN (N=513)
Trait Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age (years) 56.3(9.9) 52.9(14.4) 55.9(9.6) 52.2(14.0)
BMI (kg/m**2) 28.5(4.16) 29(4.58) 27.1(5.51) 28.4(6.19)
Waist (cm) 100.3(10.6) 102.1(11.78) 90.42(14.07) 93.21(17.9)
Weight (kg) 87.49(14.09) 82.91(14.01) 70.59(15) 69.34(15.43)
Waist/Hip Ratio 0.97(0.05) 0.96(0.09) 0.87(0.08) 0.85(0.09)
Glucose (mg.dL) 106(26.7) 106.4(20.5) 98.7(23.6) 98.6(16.3)
Homa* 8.7(7.09) 3.85(2.86) 7.26(5.93) 3.35(2.51)
Insulin (mU/L) 3.41(0.37) 14.21(8.60) 3.3(0.32) 13.2(8.08)
Triglycerides (mg/dL) 156(108) 150.7(92.9) 133(80.8) 129(80.1)
HDL Cholesterol (mg/dL) 43.2(10.9) 41.5(10) 56.9(14.6) 52.9(14)
Total PUFA n3 - g 1.43(0.58) 1.83(0.98) 1.37(0.53) 1.48(0.82)
Total PUFA n6 - g 11.03(5.12) 18.2(10.23) 9.79(4.37) 14.1(7.87)
Food Energy - kcal 1989(630) 2354(896) 1735(546) 1719(629)
Physical Activity Score - 35.2(7.39) - 33.1(4.73)
%Use %Use %Use %Use
Current Smokers (%) 16 8 18 8
Current Alcohol Users (%) 73 51 60 52
Menopausal (%) --6 9 -
Hormones (%) --2 3 2 0
Taking Hypertensive Medications (%) 12 23 9 17
Taking Diabetes Medications (%) 12 5 7 4
Taking Cholesterol Medications (%) 12 6 8 4
Data are means and standard deviation (SD) for continuous variables or % usage for categorical variables. Populations are displayed by gender for all anthropometric,
lipid and glucose variables investigated. The percent usage of tobacco, alcohol, hormone, hypertension, diabetes and cholesterol medication is also listed. The % of
menopausal women is provided for FOS, only.
*Homeostasis model assessment of insulin resistance (homa).
doi:10.1371/journal.pone.0017944.t001
Table 2. Genotypic characteristics of PLIN4 SNPs in FOS & GOLDN subjects.
PLIN4 FOS GOLDN
SNP Allele Position Feature Minor HWE-P Minor HWE-P
rs8887 G/A 4453201 39UTR 0.45 0.92 0.45 0.81
rs11673616 A/G 4457915 Intronic 0.13 0.68 0.11 0.42
rs892158 G/A 4458716 Intronic 0.16 0.38 0.14 0.91
rs7250947 G/A 4461530 Exonic 0.09 0.40 0.07 0.43
rs8102428 A/G 4467982 Intronic 0.10 0.80 0.09 0.49
rs1609717 T/C 4470450 Promoter 0.05 0.05 0.06 0.80
rs884164 T/C 4472625 Promoter 0.08 0.61 0.07 0.03
PLIN4 is found on Chromosome 19. dbSNP rs numbers for each SNP genotyped are given in column one. Major and minor alleles, and chromosomal position (GRCh
36.3) are provided, followed by the gene region in which the SNP falls. Allele frequencies and Hardy-Weinberg equilibrium p-values are given for each SNP in FOS and
GOLDN populations.
doi:10.1371/journal.pone.0017944.t002
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2=0.90), and the
upstream SNPs rs11670485 (r
2=0.91) and rs892157 (r
2=0.90).
Our data showed that the LD between rs884164 and rs8102428 in
GOLDN (r
2=0.7) and FOS (r
2=0.54) were weaker than
predicted suggesting that use of HapMap values to estimate LD
at this locus may not be ideal. rs884164 falls in the promoter
region of PLIN4 and sequence analysis using the transcription
factor motif prediction tool Mapper indicated that the major T
allele lies in a consensus NFkB motif and the C allele abrogates this
prediction [24].
miR-522 targets the 39UTR of PLIN4 containing the rs8887
minor A allele
We next investigated the functional potential of rs8887. miR-
522 maps within the chromosome 19 microRNA cluster
(C19MC), the largest known primate specific microRNA gene
cluster [25,26]. While there is evidence for miR-522 expression in
placenta, testis, thymus, brain and prostate to our knowledge
expression has not been demonstrated in adipose tissue [25,27].
Thus to determine if miR-522 is expressed in human adipoctyes,
we performed RT-PCR on total RNA samples extracted from
cultured COS7, HEK293T, HepG2 cells, and primary human
pre-adipocyte and mature adipocytes. This was followed by qPCR
using SABiosciences miR-522 specific primers. Figure 3a shows
the normalized relative expression of miR-522, with highest
expression in HepG2 cells, pre-adipocytes and adipocytes. PLIN4
has been shown to be expressed in human adipose [28].
To determine the effect of miR-522 on the PLIN4 39UTR, we
cloned into the siCHECK2 luciferase expression vector a 560-bp
region of the PLIN4 39UTR from genomic DNA of subjects
homozygous for either rs8887 allele. COS7 cells were co-
transfected with miR-522 mimic or control mimic, and with the
A allele or the G allele PLIN4 39UTR vector. The 39UTR
containing the minor A allele showed 20% reduction in luciferase
signal in the presence of miR-522 compared to control mimic
(Figure 3b). The 39UTR containing the G allele showed a non-
significant increase in luciferase signal in the presence of miR-522
compared to control mimic. These data indicate an ability of miR-
522 to bind and partially repress luciferase expression via the
PLIN4 39UTR segment when carrying the derived A allele of
rs8887. The effect of increasing concentrations of miR-522 on
PLIN4 39UTR with the A allele is saturated at 20 nM of miR-522
(Figure 3c).
Genetic drift and the PLIN4 39UTR
Genetic drift occurring in 39UTRs can result in the formation of
new MREs. These new MREs confer beneficial, neutral or
detrimental effects on the organism, leading to conservation,
neutrality or selective avoidance of the MRE, and such mecha-
nisms have had considerable influence on 39UTR evolution [19].
We examined the PLIN4 39UTR across ten mammalian species. A
phylogenetic tree depicts the evolutionary distance of PLIN4
39UTRs across these species (Figure 4a). The PLIN4 39UTR has
undergone significant change from mouse to primate and
furthermore that change is ongoing even among recently diverged
primates such as neandertal and human. Figure 4b shows an
alignment of the last 100 bases of the PLIN4 39UTR. The
reference nucleotide for all sequences except mouse, neandertal
and human is a C at the rs8887 position. The mouse has no
orthologous sequence for this segment and neandertal and human
sequence have a G or an A/G nucleotide, respectively, suggesting
the recent emergence of the 522 MRE.
To investigate if the recent rs8887 SNP is undergoing selection
across human populations, we utilized the fixation index (FST)
statistic, which measures the divergence of alleles across populations
[29]. The frequency of a particular allele in populations can vary
over time and is influenced by such forces as genetic drift and
natural selection and FST values can be used to approximate these
Figure 1. LD Plot of PLIN4 SNPs in FOS & GOLDN. LD plots were
generated in the Haploview program using unrelated individuals from
the corresponding studies. The r
2 LD estimate was used for both
populations and is reported in the figure above.
doi:10.1371/journal.pone.0017944.g001
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HapMap PHASE III data were obtained with the SNP@Evolution
web tool (Table 5) [30]. The total FST value for rs8887 was 0.132
indicating a moderate level of differentiation between populations,
suggesting rs8887 is undergoing drift.
Discussion
We report novel associations between SNPs in human PLIN4
and obesity related phenotypes. We also have identified a series of
gene by diet interactions modulating these traits. Of particular
interest rs8887 associates with a constellation of anthropometric
traits which were modulated through interaction with dietary
PUFA. In silico analysis of the PLIN4 mRNA sequence predicted
the minor A allele of rs8887 generates a novel seed site for miR-
522 and our ex vivo luciferase data indicated that miR-522 reduced
PLIN4 protein levels 20% via the PLIN4 39UTR target site created
by the rs8887 A allele. Importantly, single point mutations in
MRE seed sites have shown the ability to reduce or abolish miR-
mediated repression [31].
When 39UTR sequences drift over the course of evolution, they
are continuously exposed to potential matches with co-expressed
miRs. While conservation signal is often used to predict functional
MREs, it has been determined that a conservation signal above
background for MREs of the most recent mammalian specific
miRNA families was unlikely due to the relatively short time
between the emergence of these miRs and the occurrence of new
MREs within 39UTRs [9]. This suggests that for some of the more
recent MREs to emerge, there has not been sufficient time for
environment to determine which sites are beneficial, neutral or
detrimental with respect to the genome. It is likely that some
primate 39UTRs have been, and are, subject to drift via the
appearance of new genetic variants, resulting in loss or gain of
miR-target interactions which may have potential for phenotypic
modulation [20]. However, to date, there are few known examples
of genetic variation in miR-target sites contributing to phenotypic
variation [32].
C19MC is thought to be a product of an AluJ/AluS insertion
into chromosome 19 during an early stage of primate evolution
suggesting a role for miR-522 in higher development and
phenotypic plasticity [26]. It is likely that miR-522 is important
for development given its temporal expression in placenta and fetal
tissues, however its role in adipocytes is unknown. Our
phylogenetic analysis indicates that variation at the rs8887 position
resulting in the PLIN4 miR-522 MRE is specific to humans and
likely undergoing drift. We hypothesize that binding between
rs8887 and mir-522 results in suboptimal expression of PLIN4,
thereby contributing to the elevation in anthropometrics observed
in our association analyses. A layer of complexity in controlling
expression of the PTEN oncogene has been described as an
interaction between a microRNA and pseudogene PTENP1 [33].
We find no evidence for a PLIN4 pseudogene in the human
genome which strengthens the implications of the miR-522-PLIN4
interaction we describe here.
If the appearance of variation at the rs8887 position is recent to
human, it is tempting to speculate that the genesis of the rs8887
minor A allele may have contributed to the phenotypic
diversification distinguishing humans from other primates as it is
thought that the gain, or loss, of genetic regulatory mechanisms
are critical for the evolutionary process [34]. That this interaction
may have contributed to the evolution of the human brain is food
for thought [35].
Our association data indicate for rs8887 minor allele carriers
that elevated intake of PUFA n3 results in decreasing anthropo-
metrics compared to non-carriers. Due to what little is known of
PLIN4 regulation, it is difficult to propose a mechanism by which
the miR-522 rs8887 interaction together with PUFA n3 could
modulate anthropometrics. It is likely that PUFA n3 alters PLIN4
expression through PPAR mediated pathways [28]. Furthermore,
studies in model organisms have demonstrated anti-obesity effects
Table 3. Significant Associations of PLIN4 SNPs in the FOS and GOLDN populations - Main Effects.
FOS GOLDN Meta-Analysis
SNP Phenotype Gender Beta Se P %Var Beta Se P %Var z-score P
rs8887 BMI Both 0.614 0.221 0.005 0.396 .581 0.378 0.125 0.334 3.164 0.002
Males 0.624 0.269 0.021 0.326 0.461 0.480 2.319 0.020
Females 0.631 0.335 .060 0.704 0.586 0.230 2.231 0.026
Weight Both 3.106 1.431 0.030 0.200 2.374 2.271 0.296 0.081 2.387 0.017
Males 2.917 1.980 0.141 0.584 3.146 0.853 1.332 0.183
Females 3.524 2.010 0.080 3.465 3.242 0.286 2.050 0.040
Waist Both 0.423 0.221 0.056 0.157 0.252 0.440 0.567 0.023 1.911 0.056
Males 0.483 0.269 0.073 20.085 0.565 0.880 1.413 0.158
Females 0.381 0.334 0.253 0.397 0.656 0.556 1.278 0.201
VAT Both 199.5 67.55 0.003
Males 345.4 100.5 0.001
Females 68.7 83.97 0.413
SAT Both 229.1 90.66 0.011
Males 180.4 106.2 0.090
Females 248.9 147.2 0.054
Results of meta-analysis in FOS and GOLDN performed using a Dominant Model, due in part to low allele frequencies of several SNPs. P-values for anthropometrics were
adjusted for sex, age, smoking, physical activity (GOLDN only), alcohol use, diabetes, beta-blockers, calories from fat, PUFA n3 and n6, and estrogen and menopausal
status (FOS only) in women. Lipid and glucose p-values were also adjusted for BMI and cholesterol medications.
doi:10.1371/journal.pone.0017944.t003
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modulating the activity of various transcription factors important
to lipid metabolism [36]. It may be miR-522 is dysregulated in the
obese and thus contributes to the dysregulation of adipogenic
pathways as suggested for another C19MC member, miR-519d
[37]. Alternatively, miR-522 may be modulated by environmental
factors which influence PLIN4 through rs8887 as suggested for
several other miRs [38]. If in addition to regulating PLIN4
expression PUFA n3 down-regulates miR-522, we would expect
increasing PUFA n3 intake to have a more dramatic effect in
reducing weight for subjects carrying the minor allele compared to
non-carriers. Specifically, if the miR-522 PLIN4 interaction is
absent in those homozygous for the G allele, reducing miR-522
activity through increasing PUFA n3 will have no additional effect
on increasing PLIN4 expression, and therefore no added
contribution to weight loss. FOS subjects have on average less
PUFA n3 intake than GOLDN subjects (Table 1). In addition,
our associations for baseline anthropometrics are more significant
in FOS, while p-values for interaction with PUFA n3 are less
significant compared to GOLDN values (Tables 3, 4). The
reduced levels of PUFA n3 intake in FOS subjects possibly bias
associations toward significance of main effects, while biasing
against significance for interaction with PUFA n3. Identifying the
function(s) of miR-522 and the conditions that induce its activation
and repression will help clarify its role in mammalian development
and as a potential modulator of obesity phenotypes.
We can only speculate how lower expression of PLIN4
contributes to obesity-related phenotypes. For the related PLIN1,
one study demonstrated that obesity and high lipolysis rates are
independently associated with lower PLIN1 protein levels in
women, whereas another demonstrated reduced levels of both
PLIN1 mRNA and protein in obese compared to non-obese
subjects [39,40]. Conversely, the Plin1
2/2 mouse is characterized
by a lean phenotype. These data suggest the role and regulation of
the PAT gene family in human obesity may be different than in
model organisms.
Table 4. Significant PLIN4 by diet interactions from meta-analysis.
FOS GOLDN Meta-Analysis
SNP Phenotype PUFA Gender Beta Se P %Var Beta Se P %Var z-score P
rs8887 BMI n3 Both 20.469 0.391 0.230 0.48 21.208 0.459 0.009 0.77 22.447 0.014
Males 20.624 0.466 0.181 21.158 0.542 0.033 22.288 0.022
Females 20.438 0.625 0.484 20.964 0.838 0.251 21.216 0.224
Weight n3 Both 23.867 2.522 0.125 0.30 27.189 0.009 0.44 22.707 0.007
Males 23.778 3.430 0.271 27.080 0.057 21.964 0.049
Females 24.553 3.750 0.225 26.046 0.194 21.728 0.084
Waist n3 Both 20.461 0.391 0.238 0.23 21.444 0.544 0.008 0.55 22.445 0.015
Males 20.500 0.466 0.283 21.230 0.672 0.068 21.900 0.057
Females 20.421 0.621 0.498 21.584 0.952 0.097 21.483 0.138
rs884164 BMI n3 Both 1.077 0.458 0.019 0.17 0.875 0.694 0.208 0.13 2.655 0.008
Males 0.924 0.534 0.084 0.932 0.798 0.243 2.087 0.037
Females 0.974 0.799 0.223 1.700 1.347 0.208 1.709 0.087
Weight n3 Both 6.860 2.995 0.020 0.12 6.689 4.116 0.109 0.12 2.819 0.005
Males 6.202 3.958 0.117 8.806 5.443 0.106 2.195 0.028
Females 5.475 4.801 0.254 7.803 7.490 0.298 1.524 0.128
Waist n3 Both 1.164 0.459 0.011 0.19 20.015 0.791 0.985 0.01 2.106 0.035
Males 0.938 0.538 0.081 20.230 0.900 0.798 1.317 0.188
Females 0.920 0.793 0.247 0.761 1.543 0.622 1.239 0.216
Triglycerides n3 Both 0.086 0.046 0.062 0.13 0.111 0.069 0.106 0.31 2.448 0.014
Males 0.152 0.067 0.024 0.48 0.240 0.094 0.011 1.45 3.289 0.001
Females 0.003 0.064 0.958 20.073 0.116 0.527 20.303 0.762
n6 Both 0.014 0.006 0.011 0.24 0.005 0.007 0.479 0.11 2.503 0.012
Males 0019 0.008 0.013 0.52 0.02 0.009 0.035 1.07 3.229 0.001
Females 0.007 0.008 0.421 20.012 0.011 0.274 0.073 0.942
Glucose n3 Both 0.006 0.012 0.620 0.03 0.056 0.016 0.001 0.90 2.393 0.017
Males 0.009 0.016 0.578 0.082 0.023 0.001 2.379 0.017
Females 0.005 0.018 0.788 0.021 0.024 0.398 0.689 0.491
HDL n6 Both 20.207 0.135 0.125 0.03 20.215 0.145 0.138 0.31 22.096 0.036
Males 20.194 0.153 0.204 0.11 20.342 0.163 0.036 0.71 22.215 0.027
Females 20.086 0.252 0.734 20.019 0.267 0.942 0–.324 0.746
Gene by diet interaction for meta-analysis of FOS and GOLDN. Interactions between PLIN4 variants and dietary PUFA n3 and n6 were included in a multivariate
regression model as continuous variables. Models were adjusted as in Table 3.
doi:10.1371/journal.pone.0017944.t004
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e17944In addition to our findings with rs8887, the rs884164 variant
showed significant interaction with PUFA n3 modulating anthro-
pometric and lipid traits. The rs884164 variant was predicted to fall
in an NFkB motif. NFkB acts downstream of TNFa signaling and is
thought to contribute to the pro-inflammatory response observed
obese individuals [41]. In addition to the activation of other pro-
inflammatory cytokines, which can lead to disruptions in insulin
signaling, NFkB is thought to up-regulate lipogenic factors and
down-regulate adipogenic factors thereby increasing serum FFAs
and further contributing to the insulin resistance and CVD
associated with obesity [42]. Laurencikiene et al demonstrated in
vitro that lipolysis was abolished upon the inactivation of NFkB in
human adipocytes. Moreover, NFkB was shown to elevate PLIN1
and Hormone Sensitive Lipase (HSL) expression during lipolytic
stimulation [43]. It has been demonstrated that PUFA n3 can
modulatethe expressionlevelsofNFkB targetgenes[44].PUFAn3s
were shown to decrease levels of NFkB target genes by limiting the
translocation of NFkB subunits from the cytoplasm to the nucleus
[45]. However, the extent through which NFkB affects energy
storage and expenditure is not well characterized in humans. If and
how rs884164 may modulate PLIN4 response to PUFA through
NFkB remains to be determined.
Several variants at the PLIN4 locus are estimated to explain a
small portion of the variance observed in anthropometric traits
from main effects and by the interaction of these variants with
PUFA intake (Tables 3, 4). These estimates do not appear to
account for a large amount of phenotypic variability. However, as
with the case of FTO and BMI, common variants modulating
anthropometric traits often explain only a small amount of the
observed phenotypic variation [46]. It is likely that variation at
PLIN4 is yet another contributor to the complex nature of obesity
and its associated comorbidities.
A potential limitation to this study, given the hypothesis driven
nature of our analyses and the correlation between traits
examined, is a lack of adjusting our results for multiple-tests.
Furthermore, there was some heterogeneity in the levels of
Figure 2. The rs8887 minor A allele creates a novel miR-522
MRE in the PLIN4 39UTR. Diagram of the miR-522:PLIN4 39UTR
sequences with the A or G allele. The miR-522 seed site is highlighted in
gray, and the rs8887 variants are in bold.
doi:10.1371/journal.pone.0017944.g002
Figure 3. The PLIN4 39UTR with the A allele creates a miR-522 MRE. A) Relative miR-522 expression across indicated cell types, hek293T
(293T), Cos7 (c7), hepG2 (hG2), pre-adpocytes (pre-Ad) and adipocytes(Ad). B) Luciferase expression of pmiR-LucPLIN4-G or A constructs with miR-522
(522) or control mimic (CM). Data are expressed as relative luciferase activity to control samples. C) Luciferase expression of pmiR-LucPLIN4-A
constructs with increasing concentration of miR-522 compared to control mimic. All data represent experiments performed in triplicate. Statistical
Analysis: P values for the difference between luciferase activity obtained for LucPLIN4-A in the presence of mir-522 or control mimic (P=.0169) or
LucPLIN4-G in the presence of mir-522 or control mimic (P=.0584) were determined using the student’s paired t-test.
doi:10.1371/journal.pone.0017944.g003
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e17944statistical significance between the FOS and GOLDN populations,
which may be due to the larger sample size of FOS or may be
explained in part by differing PUFA n3 intakes between
populations. However, we are confident in our findings given
that the direction of the effect in both populations was the same,
that our meta-analysis demonstrated overall significance and that
Figure 4. Evolutionary history of the PLIN4 39UTR. A) The evolutionary history of PLIN4 was inferred using the Maximum Parsimony method. The
bootstrap consensus tree inferred from 10000 replicates is taken to represent the evolutionary history of the taxa analyzed. The percentage of replicate
trees in which the associated taxa clustered together in the bootstrap test are shown next to the branches. The MP tree was obtained using the Close-
Neighbor-Interchange algorithm with search level 3 in which the initial trees were obtained with the random addition of sequences (100 replicates). B)
Clustal W was used to align the PLIN4 39UTR sequences from H. sapiens, H. neanderthalensis, P. troglodytes, G. gorilla, P. pygmaeus, M. murinis, C.
familiaris, B. Taurus, S. scrofa, and M. musculus. The last 100 bases of the alignment are show here, with the position harboring the rs8887 SNP outlined.
doi:10.1371/journal.pone.0017944.g004
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PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e17944the rs8887 functional data support our conclusions. The type and
quantity of fat in the diet are an important factor in determining
risk for obesity. To this end, a variety of dietary recommendations
are suggested for obesity prevention and therapy. A concern
regarding these recommendations is accounting for possible
inconsistencies introduced by other factors affecting the desired
outcomes. The data presented here offer an example of this
occurrence in that subjects carrying the rs8887 minor allele are
potentially more sensitive to lowering their previously elevated
anthropometrics by increasing their PUFA n3 intake. This work
may help enable health professionals to better tailor an effective
weight-loss regimen based on a patients DNA profile.
Materials and Methods
Statistical analysis
A dominant model was applied to all SNPs classifying homozy-
gotes for the major allele in one group, and carriers and homozygotes
of the minor allele in another. Multivariate linear regression was used
for association analyses in the GOLDN and FOS populations. To
reduce variability that might obscure potential findings, multiple
covariates were incorporated into our regression model, including
age, sex, alcohol and tobacco smoking status, physical activity
(GOLDN only), hormone use and diabetes, cholesterol and
hypertension medications. To adjust for familial relationships among
subjects in both populations, the lme kinship procedure was used in R,
which allows the specification of the full correlation structure within
pedigrees into the regression equation with random effects. To
determine gene by diet interactions a SNP*dietary term was
introduced into the regression equation. These tests were adjusted
for total energy intake by adding total energy to the model, in
addition to those mentioned above. A p value,.05 was considered
significant. Response variables that did not maintain a normal
distribution were log transformed to fit the normal distribution.
Meta-analyses were performed with the software package Meta-
Analysis helper (METAL) (www.sph.umich.edu/csg/abecasis/metal)
which combines results from two or more individual studies. We
used meta analysis to weight the effect size of each study by its sample
size and combining Z statistics to determine an overall level of
significance.
39UTR Luciferase Reporter Assays
The Expand High Fidelity PCR kit (Roche) was used to amplify
the PLIN4 39UTR sequence using gDNA from subjects homozy-
gous for either the rs8887 G or A allele. Primers were designed to
amplifya560nucleotidesequence includingthe last460basesofthe
PLIN4 39UTR and 100 bases of downstream genomic sequence.
Included in the primers were the restriction enzyme sites XhoI for
the forward primer (AACTCGAGCTGTAGGAGCCTGCAAG)
and NotI for the reverse (AGCGGCCGCGACTATAAA-
TGGTTTTTTAATGAAAAAAGAAATCACT). These PCR pro-
ducts where cloned into the multiple cloning site of the
PSICHeCK2 reporter vector downstream of the Renilla luciferase
coding sequence.
COS7 cells, plated into 12-well plates (Costar), were co-
transfected with 1 mg of the pmiR-LucPLIN4-G or pmiR-
LucPLIN4-A luciferase reporter vectors and 40 nM miRIDIAN
miR-522 mimic or an equal concentration of a non-targeting
control mimic sequence (Dharmacon) using the Lipofectamine
2000 Reagent (Invitrogen). Luciferase activity was measured using
the Dual-Glo Luciferase Assay System (Promega). Renilla luciferase
activity was normalized to the corresponding firefly luciferase
activity and plotted as a percentage of the control (cells co-
transfected with the corresponding concentration of control
mimic). This experiment was performed in triplicate wells of a
12-well plate and repeated at least three times.
Study design and subjects FOS
The design and methods of the Framingham Offspring Study,
which was initiated in 1971, have been reported [47]. Blood
samples for DNA were collected between 1987 and 1991.
Anthropometric, lipid and dietary intake variables were recorded
for subjects who participated in the fifth and sixth examination
visits. Variables used in this study consist of mean values calculated
from these two exams, with the exception of fasting insulin and
HOMA measurements that were available only for subjects
participating in exam 5. Dietary intake was determined with a
semi-quantitative food frequency questionare [48]. Intakes of
PUFA (n3 and n6) where calculated for each subject and used in
our analyses as continuous variables. The Institutional Review
Boards (IRB) for Human Research at Boston University and Tufts
University/New England Medical Center approved the protocol.
All participants provided written informed consent.
Anthropometric and Biochemical determinations for FOS
Briefly, weight was measured with the individual dressed in an
examining gown and wearing no shoes. The BMI was calculated
as weight in kilograms divided by the square of height in meters.
Fasting glucose, plasma lipids, and lipoproteins were measured as
previously described [49]. To analyze SAT and VAT variables,
data from the Framingham Heart Study Multidetector Computed
Tomography Study, a population-based sub-study of the commu-
nity-based Framingham Heart Study Offspring and Third-
Generation Study cohorts were used [21].
Study design and subjects GOLDN
Study protocol approval was obtained from the Human Studies
Committee of Institutional Review Board at the University of
Minnesota, University of Utah, and Tufts Medical Center. All
Table 5. FST values for rs88887 among HapMap Phase III
data.
Populations FST
ASN 0.01678
EUR 0.00258
AFR 0.03766
AME 0.08720
AEAA 0.13228
FST: differentiation among populations.
ASN: samples of Asian,CHB, CHD, and JPT.
CHB: Han Chinese in Beijing, China.
CHD: Chinese in Metropolitan Denver, Colorado.
JPT: Japanese in Tokyo, Japan.
EUR: samples of European, CEU and TSI.
CEU: Utah residents with Northern and Western European ancestry.
TSI: Toscans in Italy.
AFR: samples of African, YRI, ASW, LWK, and MKK.
YRI: Yoruba in Ibadan, Nigeria.
ASW: African ancestry in Southwest USA.
LWK: Luhya in Webuye, Kenya.
MKK: Maasai in Kinyawa, Kenya.
AME: samples of American,GIH and MEX.
GIH: Gujarati Indians in Houston, Texas.
MEX: Mexican ancestry in Los Angeles, California.
AEAA: ASN, EUR, AFR and AME.
doi:10.1371/journal.pone.0017944.t005
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PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e17944participants provided written informed consent. The detailed
methodology and design of the GOLDN study has been described
previously [17,50]. Briefly, GOLDN is part of the Program for the
Genetic Interactions Network and is funded by the NIH.
Participants were recruited from pedigrees from two genetically
homogenous National Heart, Lung, and Blood Institute Family
Heart Study field centers in Minnesota and Utah, both
predominately white populations. There were 1086 subjects with
complete phenotype, dietary and genotype data. Dietary intake
was estimated by use of the Dietary Health Questionnaire (DHQ)
which consists of 124 food items and includes both portion size
and dietary supplement questions [51].
Anthropometric and biochemical determinations for
GOLDN
Blood samples were drawn after fasting overnight. Anthropo-
metrics and blood collection, plasma separation and processing,
and biochemical lipid measurements, including triglycerides and
HDL cholesterol, have been described previously [52]. Fasting
plasma insulin was determined by the Human Insulin Specific
RIA kit (Linco Research). Fasting plasma glucose was measured
using a hexokinase-mediated reaction on a Hitachi 911 (Roche
Diagnostics).
SNP selection and genotyping
To identify common SNPs in the human PLIN4 locus, we
searched the HapMap database for polymorphic alleles with a
minor allele frequency $5%. The PLIN4 locus was defined as
5000 bp upstream of the predicted start codon, and 2000 bp
downstream from the mRNA endpoint, a region spanning
approximately 25.1 Kb. Thirteen SNPs were identified using
these criteria.
We chose seven of these SNPs for genotyping; two promoter
(rs884164 and rs1609717), one exonic missense (rs7250947), one
39UTR (rs8887) and three intronic (rs8102428, rs892158, and
rs11673616). Analysis of the HapMap CEU population with the
Haploview program determined rs892158 (rs7260518 and
rs10406797), rs7250947 (rs8102428 and rs884164), rs11673616
(rs4991027) and rs1609717 (rs4807598) to be tagSNPs capturing
variants in LD with an r
2.0.8, predicting coverage over eleven of
thirteen SNPs in the region [53].
DNA was isolated from blood samples using DNA blood Midi
kits (Qiagen, Hilden, Germany) according to the vendor’s
recommended protocol. Ready-made 59 nucleic allelic discrimi-
nation assays were available from Applied Biosystems for PLIN4
SNPs rs8887, rs11673616, rs892158, rs8102428, and rs884164.
We used the Applied Biosystems Custom Assay design web tool to
generate functional assays for SNPs rs1609717, and rs7250947
(appliedbiosystems.com). We genotyped PLIN4 SNPs using the
Taqman assays listed above on the ABIPrism 7900HT Sequence
Detection System (Applied Biosystems). Standard laboratory
practices were used to ensure accuracy of the data.
Cell culture & RNA isolation
HepG2, COS-7 and HEK-293T (obtained from American
Type Tissue Collection) cells were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) containing 10% FBS and 2%
penicillin-streptomycin. RNA was extracted from approximately
6610
6 cells using Trizol reagent. Total RNA was reverse
transcribed using the RT2 miRNA First Strand kit (SABiosciences)
and miRNA quantified using primers specific for human miR-522
(SABiosciences qPCR assay) and values were normalized to the
housekeeping gene SNORD38b. All experiments were performed
in triplicate. Trizol whole cell lysates from 3610
6 human pre- and
mature adipocytes were purchased from Zen-Bio. Total RNA was
purified using the miRNeasy kit (Qiagen) and miRNA was
quantified using the protocol above.
Phylogenetic analysis
Nucleotide sequences for human, neandertal, chimpanzee,
gorilla, orangutan, lemur, wild boar, cow, dog and mouse were
downloaded from reference assemblies available at NCBI and
aligned with ClustalW. The evolutionary history of PLIN4 was
inferred using the Maximum Parsimony (MP) method. The
bootstrap consensus tree inferred from 10000 replicates is taken
to represent the evolutionary history of the taxa analyzed.
Branches corresponding to partitions reproduced in less than
50% bootstrap replicates are collapsed. The percentage of
replicate trees in which the associated taxa clustered together in
the bootstrap test (10000 replicates) are shown next to the
branches. The MP tree was obtained using the Close-Neighbor-
Interchange algorithm with search level 3 [2,3] in which the
initial trees were obtained with the random addition of sequences
(100 replicates) [54]. The analysis involved 10 nucleotide
sequences. There were a total of 2447 positions in the final
dataset. Evolutionary analyses were conducted in MEGA4. Total
and population FST statistics for HapMap populations where
estimated using the SNP@ volution webtool which implements
the FST calculations described in Akey et al [29].
Supporting Information
Table S1 Additional significant associations observed
for baseline and interaction association analyses. Results
of meta-analysis in FOS and GOLDN performed using a
Dominant Model. P-values for anthropometrics were adjusted
for sex, age, smoking, physical activity (GOLDN only), alcohol
use, diabetes, beta-blockers, calories from fat, PUFA n3 and n6,
and estrogen and menopausal status (FOS only) in women. Lipid
and glucose p-values where also adjusted for BMI and cholesterol
medications. Gene by diet interaction for meta-analysis of FOS
and GOLDN. Interactions between PLIN4 variants and dietary
PUFA n3 and n6 were included in a multivariate regression model
as continuous variables. Values in the top table are for main effect
analyses, and the bottom table for interactions analyses.
(DOC)
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